Idiopathic pulmonary fibrosis is a condition in which lung tissue becomes progressively scarred, making the lungs stiff and reducing the amount of oxygen that reaches the blood. It is serious, it is frequently diagnosed late, and the difference early treatment makes is significant. Pulmonary fibrosis treatment in Rewari is available at Vaayu Care under Dr. Ajit Yadav, who has particular experience in interstitial lung disease.
What IPF is
The lungs contain millions of tiny air sacs surrounded by delicate tissue through which oxygen passes into the bloodstream. In pulmonary fibrosis this tissue thickens and scars. Scarred lung cannot stretch as it should and cannot transfer oxygen efficiently. "Idiopathic" means no specific cause has been identified — it is distinguished from the many other forms of interstitial lung disease that do have identifiable triggers.
Scarring, once formed, cannot be removed. This is precisely why early diagnosis matters: treatment slows the rate at which new scarring forms, so the earlier it starts, the more lung is preserved.
Symptoms
IPF begins quietly and worsens gradually over months to years:
- Breathlessness on exertion, slowly progressive
- A persistent dry cough, often the most distressing symptom
- Fatigue and reduced stamina
- Unintended weight loss
- Clubbing — broadening and rounding of the fingertips and nails
- Fine crackles at the lung bases on examination, often likened to Velcro being pulled apart
Because the onset is slow, many people adjust their activity without registering the change and present only when breathlessness is marked. A dry cough with breathlessness that has been getting worse over six months deserves proper assessment rather than another course of cough syrup.
Who is at risk
IPF typically appears after fifty and is more common in men and in people who have smoked. A minority of cases run in families. Chronic acid reflux is frequently present. Occupational and environmental exposure to metal or wood dust, and some medicines, are associated. Because several of these overlap with other conditions, a careful history is central to distinguishing IPF from other fibrotic lung disease.
How it is diagnosed
- High-resolution CT (HRCT) of the chest is the key investigation. It shows the pattern, distribution and extent of fibrosis, and a characteristic pattern in the right clinical setting can establish the diagnosis without a biopsy.
- Pulmonary function tests including diffusion capacity (DLCO) measure how stiff the lungs have become and how well oxygen crosses into the blood. These numbers become the baseline against which all future change is judged.
- Blood tests exclude connective tissue diseases such as rheumatoid arthritis and scleroderma, which cause fibrosis needing quite different treatment.
- Six-minute walk test with oxygen monitoring shows whether oxygen levels fall on exertion.
- Bronchoscopy or surgical lung biopsy is used only in selected cases where imaging and clinical picture do not agree.
- Echocardiography screens for pulmonary hypertension, a common complication.
A confident diagnosis usually rests on the combination of clinical picture, HRCT pattern and exclusion of other causes rather than on any single test.
Treatment
Antifibrotic medication is the principal treatment. Two drugs — pirfenidone and nintedanib — slow the rate of lung function decline. They do not reverse existing scarring or make you feel better in the short term, which patients need to understand clearly. Their value is in preserving future lung function, and they need monitoring for side effects, particularly on the liver and digestion. Steroids are not routine treatment for IPF and can be harmful in it, though they are used in other interstitial lung diseases.
Oxygen therapy is assessed formally, including during exertion. Supplemental oxygen improves exercise tolerance and comfort where levels fall.
Pulmonary rehabilitation improves walking distance and quality of life and is recommended for almost everyone with IPF.
Treating reflux is important, as acid reflux is thought to contribute to ongoing lung injury.
Vaccination and prompt treatment of infection matter greatly, because a chest infection in a fibrotic lung can precipitate acute deterioration.
Lung transplant assessment is discussed early in suitable younger patients, since referral timing affects outcome.
Regular monitoring — lung function every three to six months — detects progression early and allows treatment to be adjusted.
Managing cough, breathlessness and the anxiety that accompanies them is an essential part of care, not an afterthought.
Living with pulmonary fibrosis
Stay as active as your breathing allows; rehabilitation helps considerably. Stop smoking without exception. Avoid crowds during infection season and keep vaccinations current. Learn breathing techniques that ease episodes of breathlessness. Watch for warning signs of acute worsening — a sudden increase in breathlessness over days rather than months needs urgent assessment.
When to see a specialist in Rewari
Book a consultation if you have had a dry cough and gradually worsening breathlessness for more than three months, if crackles have been heard at your lung bases, if a chest X-ray or CT has mentioned fibrosis, interstitial changes or "ILD", or if you have a connective tissue disease and are becoming breathless.
Bring all previous CT films and reports — comparing old and new imaging is often the most informative single step. Book an appointment at Vaayu Care, Rewari.
Frequently asked questions
Is pulmonary fibrosis curable?
The scarring that has already formed cannot be reversed, and there is no cure. However, antifibrotic medication slows how quickly new scarring develops, which preserves lung function for longer. Oxygen, pulmonary rehabilitation and treatment of reflux and infection improve day-to-day life. In selected younger patients, lung transplantation is a definitive option.
How long does someone live with IPF?
Outcomes vary far more widely than older statistics suggest. Some people progress slowly over many years while others decline faster. The rate of change in your own lung function over the first year is more informative than any average figure. Antifibrotic treatment, started early, has improved the outlook meaningfully.
Do steroids help pulmonary fibrosis?
Not in IPF. Steroids were once used routinely but studies showed they do not help and can cause harm in this particular condition. They remain important in several other interstitial lung diseases where inflammation rather than fibrosis dominates — which is exactly why establishing the specific diagnosis matters so much before treatment begins.
Is IPF contagious or inherited?
It is not contagious. A small proportion of cases are familial, so pulmonary fibrosis in a close relative is worth mentioning, but most cases occur in people with no family history. Smoking, certain occupational dust exposures and chronic reflux are recognised risk factors.
Why do I need a CT scan rather than just an X-ray?
A chest X-ray is not sensitive enough to show early fibrosis or to distinguish between the different patterns. High-resolution CT shows the fine detail needed to identify the pattern, judge extent, and often avoid a surgical biopsy altogether. It is also the baseline against which future scans are compared.